Mar 8 |
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
|
Mar 1 |
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
|
Feb 21 |
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
|
Feb 20 |
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
|
Feb 8 |
Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)
|
Jan 30 |
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
|
Jan 23 |
ProPhase Labs eyes higher revenue for lozenge-making unit with improved pricing
|
Jan 23 |
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
|
Nov 8 |
ProPhase Labs Q3 2023 Earnings Preview
|
Nov 2 |
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time
|